Natasha Persaud

The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC.

A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.

Investigators confirmed that prostate cancer recurrence was truly localized using biopsy and imaging before considering salvage whole-gland cryoablation.

Postoperative opioid prescriptions are associated with delayed recovery, perioperative complications, and opioid misuse, investigators noted.

There is an unmet need for systemic treatment options in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based neoadjuvant chemotherapy, according to investigators.

Receipt of neoadjuvant vs adjuvant chemotherapy did not differ significantly by clinical nodal stage.

Acute kidney injury frequently occurs during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI.

Investigators reported findings from the GÖTEBORG-2, a large, population-based randomized screening trial.

Statin use in prostate cancer is attractive given their proven cardiovascular benefits and favorable toxicity profile, according to investigators.